back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-08 13:58 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
383,332 | |
| Filed 2024-02-08 13:57 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-250,000 vol |
0 | |
| Filed 2024-02-04 10:55 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2024-01-04 15:51 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+66,668 vol |
133,332 | |
| Filed 2024-01-04 15:50 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-66,668 vol |
0 | |
| Filed 2023-05-09 19:17 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Warrants
57 - Exercise of rights
|
+24,000 vol |
24,000 | |
| Filed 2023-05-09 19:16 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-09 19:15 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$6,000
+24,000 vol $0.25 each |
48,000 | |
| Filed 2023-05-09 19:15 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Rights
57 - Exercise of rights
|
-24,000 vol |
0 | |
| Filed 2023-05-09 19:13 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+33,332 vol |
33,332 | |
| Filed 2023-05-09 19:13 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-09 19:12 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,333
+33,332 vol $0.25 each |
66,664 | |
| Filed 2023-05-09 19:12 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-33,332 vol |
0 | |
| Filed 2023-04-17 22:03 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Rights
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2023-04-17 22:03 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-17 22:01 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+33,332 vol |
33,332 | |
| Filed 2023-04-17 22:00 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-14 13:35 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+50,001 vol |
66,668 | |
| Filed 2023-03-14 13:34 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+45,000 vol |
100,000 | |
| Filed 2023-03-14 13:33 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+30,000 vol |
55,000 | |
| Filed 2023-03-14 13:32 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
+18,000 vol |
24,000 | |
| Filed 2023-03-14 13:31 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+24,999 vol |
33,332 | |
| Filed 2023-01-16 17:06 Tx date 2023-01-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,333 vol |
8,333 | |
| Filed 2023-01-16 17:06 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-16 17:06 Tx date 2023-01-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-8,333 vol |
16,667 | |
| Filed 2022-09-05 19:11 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+25,000 vol |
25,000 | |
| Filed 2022-09-05 19:11 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-05 19:11 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
25,000 | |
| Filed 2022-04-18 13:32 Tx date 2022-04-12 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,630
+600 vol $6.05 each |
6,000 | |
| Filed 2022-04-17 17:26 Tx date 2022-04-12 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$363,000
+600 vol $605.00 each |
||
| Filed 2022-04-17 17:26 Tx date 2022-04-12 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$363,000
+600 vol $605.00 each |
6,000 | |
| Filed 2022-04-17 17:25 Tx date 2022-04-11 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,420
+400 vol $6.05 each |
5,400 | |
| Filed 2022-03-28 18:51 Tx date 2022-03-28 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,641
+1,000 vol $5.64 each |
5,000 | |
| Filed 2022-03-28 18:50 Tx date 2022-03-25 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,594
+2,000 vol $5.30 each |
4,000 | |
| Filed 2022-01-21 19:49 Tx date 2022-01-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2022-01-21 19:46 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-30 16:06 Tx date 2021-11-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+1,400 vol $5.00 each |
2,000 | |
| Filed 2021-12-30 16:05 Tx date 2021-11-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+600 vol $5.00 each |
600 | |
| Filed 2021-12-30 16:04 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-29 Tx date 2016-04-14 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-312,000 vol |
13,000 | |
| Filed 2018-01-29 Tx date 2014-11-30 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+150,000 vol $0.10 each |
325,000 | |
| Filed 2018-01-29 Tx date 2014-01-27 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-675,000 vol |
75,000 | |
| Filed 2018-01-29 Tx date 2014-01-27 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-450,000 vol |
50,000 | |
| Filed 2018-01-29 Tx date 2016-04-04 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Dark Star Investments Inc. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-14,400 vol |
600 | |
| Filed 2018-01-29 Tx date 2016-04-14 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-48,000 vol |
2,000 | |
| Filed 2018-01-29 Tx date 2014-01-27 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Dark Star Investments Inc. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-135,000 vol |
15,000 | |
| Filed 2018-01-29 Tx date 2017-01-20 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+100,000 vol $0.45 each |
112,600 | |
| Filed 2018-01-29 Tx date 2016-07-25 |
$LMT
Luminor Medical Technologies Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,000
-400 vol $2.50 each |
12,600 |